Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Acelrx Pharmaceutica (ACRX)

2.15 -0.25 (-10.42%)

6/23/2017  4:00pm

Open:

2.35

Pre. Close:

2.40

High:

2.50

Low:

2.15

Volume:

4,239,546

Market Cap:

97.57M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

2.51 - 2.57

2.57 - 2.62

Low:

2.04 - 2.09

2.09 - 2.14

Close:

2.08 - 2.14

2.14 - 2.21

Technical analysis  (as of: 2017-06-23 4:31:31 PM)

Overall:

      

Stoxline posted a STRONG SELL today, downgraded from higher rating. This stock seems to be very strong for short side. So you may continue to hold the short positions or sell your long positions. You are relatively safe to short or sell as long as the BUY warning is not issued.

Target:

Six months: 2.98     One year: 3.27

Support:

Support1: 2.15    Support2: 1.79

Resistance:

Resistance1: 2.55    Resistance2: 2.80

Pivot:

2.40

Moving Averages:

MA(5): 2.41     MA(20): 2.44

MA(100): 2.79     MA(250): 2.99

MACD:

MACD(12,26): -0.07     Signal(12,26,9): -0.06

%K %D:

%K(14,3): 33.33     %D(3): 48.89

RSI:

RSI(14): 36.62

52-Week:

High: 4.08  Low: 1.95  Change(%): -21.2

Average Vol(K):

3-Month: 13399  10-Days 783

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
ACRX has closed above bottom band by 1.5%. Bollinger Bands are 19.8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 31 May 2017 13:58:27 GMT
AcelRx Pharmaceuticals To Benefit From DSUVIA Launch

Thu, 01 Jun 2017 10:52:30 GMT
AcelRx Pharmaceuticals' ZALVISO Recognized for Innovative Design with ...

Tue, 10 Jan 2017 21:33:45 GMT
AcelRx Pharmaceuticals: Blockbuster Potential Makes This $2 Stock A Strong Buy ...

Thu, 17 Nov 2016 12:06:24 GMT
AcelRx Pharmaceuticals Unveiling Results of ARX-04 SAP303 Study in Post ...

Mon, 08 May 2017 19:52:30 GMT
AcelRx Pharmaceuticals Reports First Quarter 2017 Financial Results and ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

45.38

Shares Float (M)

29.83

% Held by Insiders

34.47

% Held by Institutions

41.00

Shares Short (K)

3590

Shares Short Prior Month (K)

3610

Stock Financials

EPS

-1.050

EPS Est. Current Year

-1.100

EPS Est. Next Year

-0.820

EPS Est. Next Quarter

-0.260

Forward EPS

-0.820

Book Value (p.s.)

-0.430

PEG Ratio

Profit Margin

-273.65

Operating Margin

-203.59

Return on Assets (ttm)

-21.2

Return on Equity (ttm)

-2520.6

Qtrly Rev. Growth

2.8

Gross Profit (p.s.)

0.111

Sales Per Share

EBITDA (p.s.)

-0.738

Qtrly Earnings Growth

Operating Cash Flow (M)

-30.70

Levered Free Cash Flow (M)

-27.60

FoxReading.com

Valuation

P/E

-2.05

P/E Growth Ratio

-0.10

P/BV

-5.00

P/S

256755280.00

P/CF

-3.18

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.